首页> 美国卫生研究院文献>Einstein >Partnership for productive development of biosimilar products: perspectives of access to biological products in the Brazilian market

【2h】

Partnership for productive development of biosimilar products: perspectives of access to biological products in the Brazilian market

机译：生物仿制品生产开发的伙伴关系：巴西市场上生物制品的获取前景

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

期刊名称 Einstein
作者
Morton Aaron Scheinberg; Paulo Antonio Oldani Felix; Igor Age Kos; Maurício De Angelo Andrade; Valderilio Feijó Azevedo;
展开▼
作者单位

展开▼
年(卷),期 2018(16),3
年度 2018
页码 eRW4175
总页数 6
原文格式 PDF
正文语种
中图分类
关键词
Biosimilar pharmaceuticals Public-private sector partnerships Health services accessibility;

机译：生物仿制药;公私部门合作;卫生服务可及性;

相似文献

外文文献
中文文献
专利

1. Partnership for productive development of biosimilar products: perspectives of access to biological products in the Brazilian market [J] . Morton Aaron?Scheinberg, Paulo Antonio Oldani?Felix, Igor Age?Kos, Einstein (So Paulo) . 2018,第3期

机译：生物仿制品生产开发的伙伴关系：巴西市场上生物制品的获取前景
2. Intended use of reference products & WHO International Standards/Reference Reagents in the development of similar biological products (biosimilars). [J] . Thorpe R, Wadhwa M Biologicals: Journal of the International Association of Biological Standardization . 2011,第5期

机译：在开发类似生物产品（生物仿制药）时，应计划使用参考产品和WHO国际标准/参考试剂。
3. Biosimilar Biological Products: Development & Applications [J] . Kaiser J.Aziz Drug Delivery & Technology . 2020,第2期

机译：生物仿制生物产品：开发与应用
4. Facilitating market access for producers: addressing market access requirements, evolving consumer needs, and trends in product development and distribution [C] . Jonathan Bank, Audun Lem, James A. Young, Global Conference on Aquaculture . 2012

机译：促进生产者的市场准入：解决市场准入要求，不断发展的消费者需求以及产品开发和分配的趋势
5. 1. Capital Market Returns to New Product Development Success: Informational Effects on Product Market Advertising 2. On the Expected Success Likelihood of New Drug Development and the Design of New Drug Market Launch Programs [D] . Park, Kyung Mi. 2015

机译：1.资本市场重返新产品开发成功：对产品市场广告的信息影响2.关于新药开发的预期成功可能性和新药市场启动计划的设计
6. Comment on Analysis of Pharmacokinetic and Pharmacodynamic Parameters in EU-Versus US-Licensed Reference Biological Products: Are In Vivo Bridging Studies Justified for Biosimilar Development? [O] . Christopher J. Webster, Gillian R. Woollett -1

机译：评论对欧盟与美国许可的参考生物产品中的药代动力学和药效学参数进行分析：体内桥接研究是否适合生物仿制药的开发？
7. Intended use of Reference Products WHO International Standards/Reference Reagents in the development of Similar Biological Products (Biosimilars) [O] . Thorpe Robin, Wadhwa Meenu 2011

机译：在开发类似生物产品（生物仿制药）中预期使用参考产品和WHO国际标准/参考试剂

Partnership for productive development of biosimilar products: perspectives of access to biological products in the Brazilian market

著录项

相似文献

相关主题

期刊订阅